Our research demonstrated that miR-423-5p was upregulated in the CAF-derived exosomes and that miR-423-5p could promote chemotherapy resistance in PC by targeting GREM2 through the TGF-β pathway. This evidence concerns the gene TGFB1 and pachyonychia congenita.